06/02/2026
Reimagining Nigeria’s health security starts with local production. And local production depends on access to capital, infrastructure, and global markets.
At the February 4th NAIP 2026 Economic Outlook & CEOs Forum, themed “Reimagining Nigeria’s Health Security: Local Production, Economic Sovereignty, and Strategic Partnerships,” leaders across the pharmaceutical value chain gathered to address what it truly takes to build a resilient pharmaceutical sector in Nigeria.
Financing is never left out of these conversations.
Scaling pharmaceutical production requires capital that arrives with urgency, and financial infrastructure that evolves alongside the ambitions of local manufacturers.
This is why Rigo was present. Real impact is defined by the conversations we have and most importantly, what becomes possible after they end.
Rigo exists to ensure indigenous pharmaceutical players leave these rooms not just inspired, but equipped with funding, speed, and the ability to operate and transact globally without friction.
How Rigo is supporting the Association of Industrial Pharmacists of Nigeria(NAIP):
📌Providing both collateralized and non-collateralized funding, running into the hundreds of millions, to power operations and production at scale
📌Enabling seamless cross-border payments through Vendpay, allowing manufacturers to transact with partners across the UK, US, Canada, China, and Europe🌎🌏
When capital supports production at scale, health security stops being theoretical and becomes achievable.
As NAIP continues to drive this vision forward, Rigo is committed to working closely with the association to turn these goals into action, supporting local manufacturers with the capital and infrastructure required to deliver lasting health security.
